We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMERI.L Regulatory News (MERI)

  • There is currently no data for MERI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

15 Sep 2020 08:58

RNS Number : 0219Z
Merian Chrysalis Investment Co. Ltd
15 September 2020
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

 

15 September 2020

 

 

Merian Chrysalis Investment Company Limited (the "Company" or "Merian Chrysalis")

 

Confirmation of Recent Follow-On

 

 

- Confirmation of Klarna Holding AB follow-on investment

- Update on cash position

 

Klarna Holding AB follow-on investment

On 11 September 2020 Merian Chrysalis announced a circa £23 million follow-on investment in an unspecified portfolio holding at a materially higher valuation than that as of the June 2020 net asset value calculation. Today, the Company confirms that the asset referred to in that announcement is Klarna Holding AB ("Klarna"), which conducted a $650 million primary funding round with additional secondary sell down by some investors.

 

The new round saw significant interest from a wide range of new investors and has seen leading technology investor Silver Lake join the shareholder register. In addition, there was strong support from the existing shareholder base.

 

The round values Klarna at $10.65 billion, post money. This represents a material increase compared with the valuation of $5.5 billion achieved in August 2019, reflecting the business's strong growth over the last year - volume and revenue in the first half of 2020 were up 44% and 36% respectively, compared with the prior year - and encouraging prospects in its new markets. As a result, the business is now the highest-valued private fintech in Europe. The proceeds of the latest funding round will enable Klarna to invest in product development, geographic expansion and accelerate growth, particularly in the US, which is already performing very strongly.

 

Cash Position

As a result of the follow-on investment in Klarna, the Company's gross cash position is approximately £31 million and the value of its stake in Klarna is approximately £96 million, assuming the recent valuation round pricing is applied to the entire position and calculated using current exchange rates.

 

Richard Watts, co-portfolio manager comments:

 

"Klarna has been a driving force in revolutionising the online shopping and payments market. The company has seen a significant increase in usage during the coronavirus pandemic and the US in particular has seen a step change as consumer numbers have grown more than six-fold year on year. Klarna's expansion continues to gain pace and we're delighted to have the opportunity to increase our stake in the business, providing further support as it enters the next stage of growth."

Nick Williamson, co-portfolio manager adds:

 

"Klarna's continued strong growth and innovation is cementing its position as a leading global fintech. In our experience, market leaders are typically able to command superior economics and in turn are sought out by investors. As a result, access to this type of investment, particularly for retail investors, is extremely difficult, and we are proud that our proposition has allowed our shareholders to benefit from the material uplift in Klarna's valuation over the last year."

 

 

-ENDS-

 

 

 

For further information, please contact:

 

Merian Global Investors:

Amelie Shepherd

 

 

 

+44 (0) 20 3817 1000

 

Liberum:

Gillian Martin / Owen Matthews

 

+44 (0) 20 3100 2000

Maitland Administration (Guernsey) Limited:

Elaine Smeja

+44 (0) 1481 749 364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.merian.com/chrysalis/.

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUGRGDCLUBDGGU
Date   Source Headline
18th Dec 202012:18 pmRNSResults of Extraordinary General Meeting
17th Dec 20204:38 pmRNSDirector Declaration
11th Dec 20207:00 amRNSNet Asset Value(s)
27th Nov 20203:03 pmRNSDirector/PDMR Shareholding
27th Nov 20203:02 pmRNSDirector/PDMR Shareholding
25th Nov 20203:38 pmRNSProposed Change of Name
8th Oct 20204:23 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSResults of Capital Raise
6th Oct 202011:20 amRNSUpdate on Placing
1st Oct 20207:00 amRNSPortfolio Update
28th Sep 202010:07 amRNSPrimaryBid.com Offer
28th Sep 202010:00 amRNSProposed Placing of Equity
22nd Sep 20205:05 pmRNSHolding(s) in Company
16th Sep 20209:11 amRNSPortfolio Update
15th Sep 20208:58 amRNSPortfolio Update
11th Sep 20207:00 amRNSPortfolio Update
10th Sep 20204:41 pmRNSSecond Price Monitoring Extn
10th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Sep 202012:07 pmRNSSecond Price Monitoring Extn
10th Sep 202012:02 pmRNSPrice Monitoring Extension
8th Sep 202012:07 pmRNSSecond Price Monitoring Extn
8th Sep 202012:02 pmRNSPrice Monitoring Extension
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSNet Asset Value(s)
29th Jul 20207:00 amRNSPortfolio Update
20th Jul 20207:00 amRNSPortfolio Update
6th Jul 202012:31 pmRNSHolding(s) in Company
6th Jul 202012:28 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSInterim Accounts to 31 March 2020
23rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
23rd Jun 202012:02 pmRNSPrice Monitoring Extension
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSQuarterly NAV and COVID-19 Portfolio Update
13th May 202012:07 pmRNSSecond Price Monitoring Extn
13th May 202012:02 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSPortfolio Update
7th May 20204:40 pmRNSSecond Price Monitoring Extn
7th May 20204:35 pmRNSPrice Monitoring Extension
6th May 202012:08 pmRNSSecond Price Monitoring Extn
6th May 202012:02 pmRNSPrice Monitoring Extension
30th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 202012:08 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
9th Apr 202012:07 pmRNSSecond Price Monitoring Extn
9th Apr 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSStatement relating to COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.